About
Dr. Koestler is an executive director, of Vatera Holdings. In addition to being the chairman of the Board of Directors of Melinta Therapeutics, Dr. Koestler is a member of the Boards of Directors of ImmusanT, Inc., Novo Nordisk A/S, Momenta Pharmaceuticals Inc., Arisaph Pharmaceuticals Inc., Edgemont Pharmaceuticals, LLC, and ReSearch Pharmaceutical Services (recently sold to KKR). In his nearly 30-year career in the pharmaceutical industry, Dr. Koestler established a track record of building high-performance teams that drove global success in research and development. Most recently he served as executive vice president of Schering Corporation and president of Schering-Plough Research Institute (SPRI), the pharmaceutical research and development arm of Schering-Plough Corporation. Under his leadership, the company developed an industry-leading pipeline that contributed to the turnaround of the business. Dr. Koestler’s accomplishments include over 80 product approvals including over 3
Position in the VCSift Database
- • 5 investors at Vatera Healthcare Partners are tracked.
- • 1 investors hold the Executive Director Health Care role in VCSift. Thomas Koestler is one of them.
- • 10,621 investors are based in New York, New York, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- New York, US
Contact Information
Find more investors like Thomas
Search Investors